Erythropoietin Promotes Survival of Retinal Ganglion Cells in DBA/2J Glaucoma Mice
Investigative Ophthalmology & Visual Science2007Vol. 48(3), pp. 1212–1212
Citations Over TimeTop 10% of 2007 papers
Lichun Zhong, John M. Bradley, William Schubert, Ednan Ahmed, Anthony P. Adamis, David T. Shima, Gregory S. Robinson, Yin‐Shan Ng
Abstract
EPO promoted RGC survival in DBA/2J glaucomatous mice without affecting IOP. These results suggest that EPO may be a potential therapeutic neuroprotectant in glaucoma.
Related Papers
- → Activity increase in EpoR and Epo expression by intranasal recombinant human erythropoietin (rhEpo) administration in ischemic hippocampi of adult rats(2014)14 cited
- → Erythropoietin and Erythropoietin Receptor in Colorectal Cancer(2008)13 cited
- [Non erythropoietic effects of Erythropoietin].(2019)
- → Immunohistochemical Localization of Erythropoietin (Epo) and Erythropoietin Receptor (EpoR) in Developing Human Brain ♦ 267(1997)
- Research Progress of Carbamylated Erythropoietin(2011)